Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sabat

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
The Journal of Investigative Dermatology|December 12, 2018
The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and DestructionEllen Witte-Händel, Kerstin Wolk, Athanasia Tsaousi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2025
Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter studyKerstin Wolk, Giorgia Cugno, Georgios Kokolakis, et al.
Dermatology and Therapy|October 8, 2025
Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in GermanyKerstin Wolk, Dagmar Wilsmann-Theis, Nessr Abu Rached, et al.
Frontiers in Medicine|September 19, 2025
Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativaGiorgia Cugno, Sylke Schneider-Burrus, Georgios Kokolakis, et al.
The Journal of Experimental Medicine|December 10, 2009
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17Melba Muñoz, Markus M Heimesaat, Kerstin Danker, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
Frontiers in Medicine|June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin DiseasesHideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 4, 2012
[New insights into fumaric acid esters (Fumaderm ®):results of the 2nd Expert Workshops]Ulrich Mrowietz, Peter Altmeyer, Matthias Augustin, et al.
The Journal of Clinical Investigation|December 5, 2023
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativaKelsey R van Straalen, Feiyang Ma, Pei-Suen Tsou, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
The Journal of Investigative Dermatology|December 12, 2018
The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and DestructionEllen Witte-Händel, Kerstin Wolk, Athanasia Tsaousi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2025
Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter studyKerstin Wolk, Giorgia Cugno, Georgios Kokolakis, et al.
Dermatology and Therapy|October 8, 2025
Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in GermanyKerstin Wolk, Dagmar Wilsmann-Theis, Nessr Abu Rached, et al.
Frontiers in Medicine|September 19, 2025
Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativaGiorgia Cugno, Sylke Schneider-Burrus, Georgios Kokolakis, et al.
The Journal of Experimental Medicine|December 10, 2009
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17Melba Muñoz, Markus M Heimesaat, Kerstin Danker, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
Frontiers in Medicine|June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin DiseasesHideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 4, 2012
[New insights into fumaric acid esters (Fumaderm ®):results of the 2nd Expert Workshops]Ulrich Mrowietz, Peter Altmeyer, Matthias Augustin, et al.
The Journal of Clinical Investigation|December 5, 2023
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativaKelsey R van Straalen, Feiyang Ma, Pei-Suen Tsou, et al.
Pageof 13